Concepedia

Risk-based Control Strategy

A Risk-Based Control Strategy is a systematic framework that prioritizes and tailors control measures according to the level and nature of identified impurity risks to ensure product quality within pharmaceutical development and manufacturing.

60

Publications

2.6K

Citations

313

Authors

159

Institutions

Publications per year

2017–2026

28

Parents

Publications

60

A Risk-Based Strategy Improves Prostate-Specific Antigen–Driven Detection of Prostate Cancer

Monique J. Roobol, Ewout W. Steyerberg, Ries Kranse et al. · European Urology · 2009 · 290 citations

, , +16

A systematic approach to risk management for construction

Anthony Mills · Structural Survey · 2001 · 274 citations

, , +14

A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study

Sheri L. Spunt, Lynn Million, Yueh-Yun Chi et al. · The Lancet Oncology · 2019 · 173 citations · Full text

, , +11

Avoiding Destructive Remediation at DOE Sites

F. W. Whicker, Thomas G. Hinton, M. MacDonell et al. · Science · 2004 · 107 citations

, , +17

Soil Pollution Management in China: A Brief Introduction

Tiankui Li, Yi Liu, Yi Liu et al. · Sustainability · 2019 · 107 citations · Full text

, , +16

1–5 of 60

Authors

313

  1. RL
    Rodney L. Parsons

    Bristol-Myers Squibb (United States), United States

    2 publications · 47 citations

    2

    h-index

  2. CH
    Chris H. Bangma

    Erasmus MC, Netherlands

    2 publications · 320 citations

    2

    h-index

  3. BB
    Bojan Blagojević

    University of Novi Sad, Serbia

    2 publications · 42 citations

    2

    h-index

  4. HH
    Haijun Hu

    Xi'an Jiaotong University, China

    2 publications · 121 citations

    2

    h-index

  5. MV
    Madalena Vieira‐Pinto

    University of Trás-os-Montes and Alto Douro, Portugal

    2 publications · 42 citations

    2

    h-index

1–5 of 313

Institutions

159

  1. Merck & Co., Inc., Rahway, NJ, USA (United States)

    Rahway, United States

    3 h-index

    4 publications

    228 citations

  2. Eli Lilly (United States)

    Indianapolis, United States

    3 h-index

    7 publications

    149 citations

  3. Bristol-Myers Squibb (United States)

    New York, United States

    3 h-index

    7 publications

    87 citations

  4. University of Novi Sad

    Novi Sad, Serbia

    2 h-index

    3 publications

    62 citations

  5. Erasmus MC

    Rotterdam, The Netherlands

    2 h-index

    8 publications

    2.1K citations

  6. Technical University of Denmark

    Kongens Lyngby, Denmark

    2 h-index

    7 publications

    224 citations

  7. Health and Safety Executive

    Bootle, United Kingdom

    2 h-index

    3 publications

    167 citations

  8. Amgen (United States)

    Thousand Oaks, United States

    2 h-index

    9 publications

    483 citations

1–8 of 159

Venues

  1. Organic Process Research & Development

    4 publications · 110 citations

    4

    h-index

  2. 4

    h-index

  3. Food Control

    3 publications · 52 citations

    3

    h-index

  4. Safety Science

    3 publications · 97 citations

    3

    h-index

  5. European Urology

    2 publications · 320 citations

    2

    h-index

1–5